Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
28.0%
% of FTXH's 51 holdings also in XPH
34.1%
% of XPH's 41 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
BRISTOL-MYERS SQUIBB CO | 6.6% | 4.2% | 4.2% |
|
JOHNSON & JOHNSON | 7.0% | 4.0% | 4.0% |
|
PFIZER INC | 7.5% | 3.7% | 3.7% |
|
ELI LILLY & CO | 4.2% | 3.7% | 3.7% |
|
ZOETIS INC | 3.3% | 3.9% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to XPH
|
ABBVIE INC | 7.5% |
|
UNITED THERAPEUTICS CORP | 4.6% |
|
AMGEN INC | 4.1% |
|
REGENERON PHARMACEUTICALS | 4.1% |
|
VERTEX PHARMACEUTICALS INC | 3.9% |
|
GILEAD SCIENCES INC | 3.9% |
|
PFIZER INC | 3.7% |
|
CARDINAL HEALTH INC | 3.4% |
|
BIOGEN IDEC INC | 3.1% |
|
MERCK & CO. INC. | 3.0% |
FTXH Underweight Relative to XPH
|
AXSOME THERAPEUTICS, INC. | -4.5% |
|
CORCEPT THERAPEUTICS INC | -3.8% |
|
CATALENT INC | -3.8% |
|
ROYALTY PHARMA PLC CLASS A | -3.6% |
|
INTRA-CELLULAR THERAPIES INC | -3.4% |
|
OCULAR THERAPEUTIX INC | -2.8% |
|
CASSAVA SCIENCES, INC. | -2.8% |
|
ARVINAS, INC. | -2.6% |
 |
PERRIGO CO | -2.4% |
|
AMPHASTAR PHARMACEUTICALS INC | -2.4% |